Concentrating capacity in ifosfamide-induced severe renal dysfunction

R Rossi1, A Gödde, A Kleinebrand

  • 1University Children's Hospital, Münster, Germany.

Renal Failure
|September 1, 1995
PubMed

Insights

Defective renal concentrating capacity is rare in ifosfamide-induced renal dysfunction, primarily affecting patients with overt Fanconi syndrome. Early evaluation of concentrating capacity and sodium handling is crucial to prevent dehydration risks.

Area of Science:

  • Nephrology
  • Oncology
  • Pharmacology

Background:

  • Ifosfamide chemotherapy can cause renal dysfunction, including Fanconi syndrome.
  • Previous studies suggest subclinical renal impairment may present with low urine osmolarity.
  • The frequency of impaired concentrating capacity in ifosfamide-induced Fanconi syndrome requires further investigation.

Purpose of the Study:

  • To determine the frequency of defective renal concentrating capacity in patients with ifosfamide-induced Fanconi syndrome or severe proximal tubular dysfunction.
  • To assess the relationship between overt Fanconi syndrome and impaired urinary concentrating ability.

Main Methods:

  • Evaluated 7 patients with overt Fanconi syndrome and 5 with subclinical tubulopathy.
  • Measured urinary osmolarity after overnight fasting and DDAVP (1-D-amino-8-D-arginine vasopressin) administration.
  • Assessed proximal tubular solute reabsorption and glomerular filtration rate.

Main Results:

  • Five of 7 patients with overt Fanconi syndrome showed decreased urinary osmolarity in at least one test.
  • No patients with subclinical tubular damage exhibited decreased osmolarity.
  • Increased sodium excretion was observed in 4 patients with overt Fanconi syndrome.

Conclusions:

  • Impaired renal concentrating capacity is uncommon in ifosfamide-induced renal dysfunction and is limited to patients with overt Fanconi syndrome.
  • Patients with overt Fanconi syndrome require evaluation of concentrating capacity and sodium handling.
  • Decreased concentrating capacity and increased sodium excretion increase dehydration risk.
Abstract

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...